Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.


TSXV:HEM - Post by User

Bullboard Posts
Post by dt_coreon Mar 10, 2011 3:43pm
276 Views
Post# 18267424

Agreement with John Deere

Agreement with John Deere

Hemisphere, John Deere Sign Compatibility Agreement For Aftermarket eDriveX

Hemisphere GPS announced a software license agreement with Deere & Company that enables Hemisphere GPS to enhance aftermarket compatibility of its Outback eDriveX automated steering system with John Deere’s new AutoTrac-ready tractors.

Outback Guidance systems are currently compatible with existing John Deere machinery, but the new license agreement allows Hemisphere GPS continued compatibility for the aftermarket installation of eDriveX. The result is a simplified installation and seamless automated steering operation on John Deere’s 2011 AutoTrac-ready tractors.

Hemisphere GPS’ Outback eDriveX automatically steers farm machinery to centimeter-level accuracy. As a result, farmers easily plant seed and apply chemicals only where needed – minimizing application costs, reducing driver fatigue and increasing productivity. Hemisphere GPS’ newly announced eTurns, the latest eDriveX feature, automatically steers the turn at the end of each row and will be available with the new John Deere AutoTrac Ready compatible version of eDriveX.

"Our agreement with John Deere ensures that we continue to provide customers with our leading automated steering systems in their most popular line of new tractors,” said Kip Pendleton, Senior Vice President and General Manager, Agriculture at Hemisphere GPS. "Our success at developing precision farming solutions for all types and brands of farm machinery means nearly all farmers can benefit from the productivity gains of our Outback Guidance products.”

Bullboard Posts